1 / 49

Principles of Drug Action

Principles of Drug Action. Prinsip-prinsip aksi obat Sugiyanto Lab. Farmakologi & Toksikologi Fak . Farmasi UGM. General Overview.

nhenderson
Télécharger la présentation

Principles of Drug Action

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Principles of Drug Action Prinsip-prinsipaksiobat Sugiyanto Lab. Farmakologi & Toksikologi Fak. Farmasi UGM

  2. General Overview • A few drugs act by virtue of their physicochemical properties, e.g. laxative agent (MgSO4), general anesthetics (based on its lipid solubility (?), osmotic diuretics (mannitol) • Some drugs act as false substrates (sulphonamides) or inhibitor for certain transport systems (cardiac glycosides) or enzymes (NSAIDs) • Most drugs produce their effects by acting on specific protein molecules, usually located in the cell membrane. These proteins are called receptors

  3. Prinsipaksiobat

  4. Receptor, Agonist & Antagonist • Receptors normally respond to endogenous chemicals in the body. • These chemicals are either synaptic transmitter substances (neurotransmitters) or hormones, for example acetylcholine, epinephrine, insulin, aldosterone etc. • Chemicals or drugs that activate receptors and produce a response are called agonist. • Drugs or chemicals that combine to receptors but do not activate them are called antagonist

  5. Receptors • They are protein molecules which are normally activated by neurotransmitters or hormones. • Many receptors have now been cloned and their amino acid sequences determined. • The 4 main type of receptors are: • 1. Agonist-gated receptors are made up from subunits which form a central ion channel (e.g. nicotinic receptor) • 2. G-protein-coupled receptors form a family of receptors with seven membrane-spanning helices

  6. Receptors • 3. Nuclear Receptors (Intracellular receptors, Protein Synthesis-regulating Receptors) for steroid hormones and thyroid hormones • 4.Kinase-linked receptors (Ligand-regulated Enzymes) adalah reseptor permukaan membran yg biasanya mempunyai aktivitas kinase tirosin intrinsik, sebagai contoh: reseptor insulin, reseptor sitokin dan reseptor faktor pertumbuhan

  7. Reseptorasetilkolinnikotinik : • Suatu protein pentamer yang terdiri dari 5 subunit yaitu 2βγδ • Terkait dengan kanal Na+ • berlokasi di neuromuscular junction, ganglia otonom, medula adrenal, dan CNS • pertama kali dikarakterisasi dengan kemampuannya mengikat nikotin

  8. Reseptor GABA

  9. Contohreseptorterkopel protein G • Reseptor asetilkolin muskarinik • Reseptor adrenergik • Reseptor dopamin • Reseptor angiotensin

  10. Reseptor terkopel Protein G • merupakan keluarga terbesar reseptor permukaan sel • menjadi mediator dari respon seluler berbagai molekul, seperti: hormon, neurotransmiter, mediator lokal, dll. • merupakan satu rantai polipetida tunggal, keluar masuk menembus membran sel sampai 7 kali  disebut memiliki 7 transmembran

  11. Some examples of Nuclear Receptor (Protein synthesis-regulating Receptors)

  12. ContohKinase-linked Receptor (Ligand-regulated Enzymes) Reseptor Insulin

  13. Drug-receptor Interactions • The activation of receptors by an agonist is coupled to the physiological or biochemical responses by transduction mechanisms that often (but not always) involve molecules called second messengers (for example Ca2+, inositol triphosphate, diacylglycerol and cAMP) • The interaction between a drug and the binding site of the receptor depends on the complementary of “fit” of the 2 molecules. • The closser the fit and the grater the number of bonds (usually non-covalent), the stronger will be the attractive forces between them, and the higher the affinity of the drug for the receptor.

  14. Aktivasi GPCR (G protein-coupled receptor) melaluisistemfosfolipase • merupakan salah satu mekanisme transduksi signal yang penting • diawali dg pengikatan suatu ligan pada reseptor  mengaktivasi enzim fosfolipase C membelah PIP2menjadi IP3dan DAG • PIP2 = fosfatidil inositol bis-fosfat  merupakan hasil degradasi fosfatidil inositol pada membran sel dg bantuan enzim PI kinase • IP3= inositol trifosfat  berikatan dengan reseptor spesifik pada retikulum endoplasmik yang tekait dg kanal Ca++  memicu pelepasan kalsium intrasel  kontraksi sel, pelepasan hormon/neurotransmiter, eksositosis • DAG = diasil gliserol  mengaktivasi protein kinase C  memfosforilasi residu serine/threonin kinase pada sel target

  15. Signal molecule PI 4,5-biphosphate (PI(4,5)P2) G-protein linked receptor Activated Phospholipase Cb diacylglycerol Activated PKC Activated G a subunit inositol 1,4,5-triphosphate (IP3) Ca++ Open IP3-gated Ca++ channel lumen of endoplasmic reticulum

  16. Cara kerjareseptor insulin dlmpengambilanglukosa

  17. Specificity & selectivity • The ability of a drug to combine with one particular type of receptor is called specificity. • No drug is truly specific but many have a relatively selective action on one type of receptor. • Drugs are prescribed to produce a therapeutic effect but they often produce additional unwanted effects which range from the trivial (slight nausea) to the fatal (aplastic anaemia)

  18. Neurotransmitters • Neurotransmitter substances are chemicals released from nerve terminals which diffuse across the synaptic cleft and bind to the receptors. • The neurotransmitter activates receptors, presumably by changing their conformation, and triggers a sequences of post-synaptic events resulting in, for example, muscle contraction or glandular secretion. • Following its release, the transmitter is inactivated by either degradation (e.g. acetylcholine) or reuptake (e.g. norepinephrine, GABA). • Many drugs act by either reducing or enhancing synaptic tranmission.

  19. Hormones • Hormones are chemicals released into bloodstream; they produce their physiological effects on tissues possessing the necessary specific hormone receptors. • Drugs may interact with the endocrine system by inhibiting (e.g. antithyroid drugs) or increasing (e.g. oral antidiabetic agents) hormone release. • Other drugs interact with hormone receptors which may be activated (e.g. steroidal anti-inflammatory drugs) or blocked (e.g. oestrogen antagonists). • Local hormones (autacoids) such as histamine, serotonin (5-HT), kinins and prostaglandins are released in pathological processes.

  20. Hormones • Propil tio urasil (PTU) obat antitiroid • Glimepirid dan glibenklamid, obat golongan sulfonilurea, digunakan untuk memacu skresi hormon insulin (abtidiabetik) • Efek dari histamin dapat dihambat oleh antihistamin • Beberapa obat dapat menghambat biosintesis prostaglandin (obat-obat anti inflamasi non-steroid, NSAIDs)

  21. Neurotransmitter Asetilkholin Asetilkholin: • molekul pertama yang diidentifikasi sebagai neurotransmitter • aksinya pada sistem syaraf otonom di perifer maupun CNS • Di sistem syaraf perifer: • Neurotransmitter sistem syaraf parasimpatik (kholinergik) • memiliki 2 macam reseptor yaitu nikotinik dan muskarinik • Di sistem syaraf pusat (CNS): • berperan antara lain dalam regulasi belajar (learning), memori,kontrol gerakan, dan mood (perasaan)  contoh: penyakit Alzheimer (pikun) disebabkan karena degenerasi sistim kolinergik

  22. Reseptor kanal ion (ionotropik) • Teraktivasi sebagai respon terhadap ligan spesifik • Selektif terhadap ion tertentu • Terlibat dalam signaling sinaptik yang cepat (yang lambat : melalui reseptor protein G) • Contoh : reseptor asetilkolin nikotinik reseptor GABAa reseptor glutamat (NMDA) reseptor serotonin (5-HT3)

  23. DRUG-receptor INTERACTION Kinetics, effect and fate

  24. Kinetics of drug-receptor interaction

  25. Kinetics…….. • A + R [AR] Response • Rate of association= k1 [A][R] • Rate of dissociation = k2 [AR] • At equilibrium: • Rate of association = rate of dissociation • k1 [A][R] = k2 [AR] • k2/k1 = [A][R]/ [AR] = kD

  26. Kinetics…. (some assumptions) • 1.reaksi antara agonis dan reseptor adalah reversibel • 2. kedua reaktan tersedia dalam bentuk bebas atau terikat dan tidak termasuk bentuk lain, mis hasil degradasi yang tidak terlibat dalam reaksi tersebut • 3. Semua tempat di reseptor mempunyai affinitas yg sama terhadap agonis dan independen

  27. Plot terhadap waktu…. • d([AR]/dt = k1[A][R] – k2[AR] • Plotting of [AR] as function of time yields an hyperbolic curve and asymptotic relationships for the formation of [AR] as equilibrium was approach

  28. DRUG-RECEPTOR INTERACTION

  29. Difference in configuration

  30. Protein binding & drug effect

  31. Agonist & Antagonist

  32. Affinity & efficacy

  33. Competitive antagonism

  34. Type of antagonism • Competitive antagonism: atropine, ipratropium, hyoscine for ACTH-receptor • Irreversible antagonism: phenoxybenzamine for α-adrenoceptor • Non-competitive antagonism: Ca-channel blockers • Chemical antagonism: protamine vs heparin • Physiological antagonism: prostacyclin against thromboxane A2

  35. Kinetics of drug-receptor interaction

  36. Type of receptors

  37. Activation of receptor

  38. The role of Second messengers

  39. Farmacokinetics

  40. Adverse effect of drugs

  41. Adverse effect of drugs

  42. Adverse effect of drugs

More Related